Biochar produced from anaerobically digested fiber reduces phosphorus in dairy lagoons

This study evaluated the use of biochar produced from anaerobic digester dairy fiber (ADF) to sequester phosphorus (P) from dairy lagoons. The ADF was collected from a plugged flow digester, air-dried to <8% water content, and pelletized. Biochar was produced by slow pyrolysis in a barrel retort. The potential of biochar to reduce P in the anaerobic digester effluent (ADE) was assessed in small-scale filter systems through which the effluent was circulated. Biochar sequestered an average of 381 mg L P from the ADE, and 4 g L ADF was captured as a coating on the biochar. There was an increase of total (1.9 g kg), Olsen (763 mg kg), and water-extractable P (914 mg kg) bound to the biochar after 15 d of filtration. This accounted for a recovery of 32% of the P in the ADE. The recovered P on the biochar was analyzed using P nuclear magnetic resonance for P speciation, which confirmed the recovery of inorganic orthophosphate after liquid extraction of the biochar and the presence of inextractable Ca-P in the solid state. The inorganic phosphate was sequestered on the biochar through physical and weak chemical bonding. Results indicate that biochar could be a beneficial component to P reduction in the dairy system.     

Genetic diagnosis and clinical evaluation of severe fetal akinesia syndrome

Objective

In this retrospective study, we describe the clinical course, ultrasound findings and genetic investigations of fetuses affected by fetal akinesia.

Materials and Methods

We enrolled 22 eukaryotic fetuses of 18 families, diagnosed with fetal akinesia between 2008 and 2016 at the Department of Obstetrics and Feto-Maternal Medicine at the Medical University of Vienna. Routine genetic evaluation included karyotyping and chromosomal microarray analysis. Retrospectively, exome sequencing was performed in the index case of 11 families, if stored DNA was available. Confirmation analyses and genetic diagnosis of siblings were performed by using Sanger sequencing.

Results

Whole exome sequencing identified pathogenic variants of CNTN1, RYR1, NEB, GLDN, HRAS and TNNT3 in six cases of 11 families. In three of these families, the variants were confirmed in the respective sibling.

Conclusions

The present study demonstrates a high diagnostic yield of exome sequencing in fetuses affected by akinesia syndrome, especially if family history is positive. Still, in a large part the underlying genetic cause remained unknown, whereas precise clinical evaluation in combination with exome sequencing shows to be the best tool to find the disease causing variants.